AGP Picks
View all

Asia Healthcare Industry Digest
Provided by AGP

Asia Healthcare Industry Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

November 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30

Press releases published on September 14, 2026

Miracle Surrogacy Welcomes Over 100 Families to Back-to-School Celebrations
Sep. 14, 2026

Miracle Surrogacy Welcomes Over 100 Families to Back-to-School Celebrations

Indeterminate EIN Presswire
Integral BioSystems Files Additional Extensive NanoM-Wafer™ PCTs in Major Global Jurisdictions to Secure Evolving IP
Sep. 14, 2026

Integral BioSystems Files Additional Extensive NanoM-Wafer™ PCTs in Major Global Jurisdictions to Secure Evolving IP

Indeterminate EIN Presswire
Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Sep. 14, 2026

Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
From Former Patient to Clinical Leader: Oxford Treatment Center Promotes Kate Bell to Outpatient Clinical Manager
Sep. 14, 2026

From Former Patient to Clinical Leader: Oxford Treatment Center Promotes Kate Bell to Outpatient Clinical Manager

Indeterminate GlobeNewswire
Ascendis Announces Planned $400 Million Share Repurchase Program
Sep. 14, 2026

Ascendis Announces Planned $400 Million Share Repurchase Program

Indeterminate GlobeNewswire
Ascendis to Regain Rights to TransCon® Technology in Metabolic and Cardiovascular Diseases
Sep. 14, 2026

Ascendis to Regain Rights to TransCon® Technology in Metabolic and Cardiovascular Diseases

Indeterminate GlobeNewswire
Curium™ announces FDA approval of BEXLUTRY lutetium Lu 177 dotatate injection for adults with SSTR-positive GEP-NETs
Sep. 14, 2026

Curium™ announces FDA approval of BEXLUTRY lutetium Lu 177 dotatate injection for adults with SSTR-positive GEP-NETs

Indeterminate GlobeNewswire
Singaporean Stroke Survivor and Author Terence Ang Receives International Recognition Through the NYC Big Book Award®
Sep. 14, 2026

Singaporean Stroke Survivor and Author Terence Ang Receives International Recognition Through the NYC Big Book Award®

Indeterminate EIN Presswire
Onspire Health Marketing Clients Earn Five Gold Healthcare Advertising Awards
Sep. 14, 2026

Onspire Health Marketing Clients Earn Five Gold Healthcare Advertising Awards

Indeterminate GlobeNewswire
DLH Appoints Brooke Pierce President of Health Business Group
Sep. 14, 2026

DLH Appoints Brooke Pierce President of Health Business Group

Indeterminate GlobeNewswire
VandS Clinic Seoul Highlights Transparent Pricing for International Patients
Sep. 14, 2026

VandS Clinic Seoul Highlights Transparent Pricing for International Patients

Indeterminate EIN Presswire
Agomab Announces Positive Phase 1 Results for AGMB-447 in Patients with Idiopathic Pulmonary Fibrosis and Design of Phase 2 INSPIRIA Study
Sep. 14, 2026

Agomab Announces Positive Phase 1 Results for AGMB-447 in Patients with Idiopathic Pulmonary Fibrosis and Design of Phase 2 INSPIRIA Study

Indeterminate GlobeNewswire
PetMeds Appoints Andrew Parry as Chief Technology Officer
Sep. 14, 2026

PetMeds Appoints Andrew Parry as Chief Technology Officer

Indeterminate GlobeNewswire
Revolution Medicines Announces U.S. FDA Breakthrough Therapy Designation for RASONQUE™ (daraxonrasib) in Combination with Chemotherapy for First Line Metastatic Pancreatic Cancer
Sep. 14, 2026

Revolution Medicines Announces U.S. FDA Breakthrough Therapy Designation for RASONQUE™ (daraxonrasib) in Combination with Chemotherapy for First Line Metastatic Pancreatic Cancer

Indeterminate GlobeNewswire
NurExone and NanoPass Technologies Ltd. to Collaborate on Integrated Exosome Delivery Approach for Regenerative Eye and Skin Applications
Sep. 14, 2026

NurExone and NanoPass Technologies Ltd. to Collaborate on Integrated Exosome Delivery Approach for Regenerative Eye and Skin Applications

Indeterminate GlobeNewswire
Sionna Therapeutics Announces Plans to Advance SION-451 + SION-2222 Dual Combination into Phase 2a Proof-of-Concept Trial
Sep. 14, 2026

Sionna Therapeutics Announces Plans to Advance SION-451 + SION-2222 Dual Combination into Phase 2a Proof-of-Concept Trial

Indeterminate GlobeNewswire
Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual Meetings
Sep. 14, 2026

Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual Meetings

Indeterminate GlobeNewswire
Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results
Sep. 14, 2026

Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results

Indeterminate GlobeNewswire
BioVie to Host Conference Call to Discuss Topline Data from Phase 2 ADDRESS-LC Trial and the Potential of Bezisterim in Long Covid
Sep. 14, 2026

BioVie to Host Conference Call to Discuss Topline Data from Phase 2 ADDRESS-LC Trial and the Potential of Bezisterim in Long Covid

Indeterminate GlobeNewswire
Benitec Biopharma Releases Full Year 2026 Financial Results and Provides Operational Update
Sep. 14, 2026

Benitec Biopharma Releases Full Year 2026 Financial Results and Provides Operational Update

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Asia Healthcare Industry Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.